Clinical trial
Allogeneic Adoptive Immunochemotherapy For Treatment Of Renal Cell Carcinoma
NCT00073879 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Allogeneic Adoptive Immunochemotherapy For Treatment Of Renal Cell Carcinoma
- Lead sponsor
- Baylor College of Medicine
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2003
- Completion date
- April 30, 2004
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
kidney cancer